NCT00137462
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Union Grove, Alabama, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site Los Angeles, California, United States